Aspect Biosystems, a pioneer in the field of bioprinted tissue therapeutics, recently closed a $115 million Series B financing round aimed at advancing its groundbreaking technology in regenerative medicine. This achievement, led by Dimension and supported by investors such as Novo Nordisk and
The Blood and Cell Advocacy Register (BCAR) is a newly launched consortium that aims to revolutionize the development and commercialization of advanced therapy medicinal products (ATMPs). Formed in December 2024, BCAR brings together experts and organizations from the blood and cell industries to
The advancements in muscle regeneration technology by Swiss biotech company MUVON Therapeutics are making waves, especially in the realm of treating stress urinary incontinence in women. This breakthrough holds the potential to improve the quality of life for millions while extending healthspan.
In the laboratories of Matricelf, located in Nes Ziona, Israel, an innovative development endeavor is underway, holding the potential to revolutionize the treatment of spinal cord injuries. Established in 2019 by Professor Tal Dvir and Dr. Alon Sinai, Matricelf is at the forefront of creating
The field of biochemical engineering is witnessing an innovative approach with the development of fine-bubble engineering techniques. By focusing on the manipulation of both nanobubbles (NBs) and microbubbles (MBs), researchers aim to improve the efficiency and effectiveness of various bioprocess
The effort to control the H5N1 avian influenza outbreak has intensified, with health and agricultural authorities ramping up their measures to address its significant threats to human health and agricultural stability. The Food and Drug Administration (FDA) has begun testing cheese made from raw
